T. Rowe Price Associates’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-15,543
| Closed | -$1.31M | – | 2570 |
|
|
2017
Q4 | $1.31M | Buy |
15,543
+3
| +0% | +$252 | ﹤0.01% | 1674 |
|
|
2017
Q3 | $1.8M | Buy |
15,540
+1,221
| +9% | +$141K | ﹤0.01% | 1583 |
|
|
2017
Q2 | $1.67M | Sell |
14,319
-41,211
| -74% | -$4.81M | ﹤0.01% | 1598 |
|
|
2017
Q1 | $6.85M | Sell |
55,530
-42,924
| -44% | -$5.3M | ﹤0.01% | 1391 |
|
|
2016
Q4 | $13.4M | Sell |
98,454
-18,832
| -16% | -$2.56M | ﹤0.01% | 1248 |
|
|
2016
Q3 | $23.3M | Buy |
117,286
+4,652
| +4% | +$926K | ﹤0.01% | 1078 |
|
|
2016
Q2 | $14.6M | Sell |
112,634
-1,510
| -1% | -$196K | ﹤0.01% | 1199 |
|
|
2016
Q1 | $10.7M | Sell |
114,144
-3,205
| -3% | -$300K | ﹤0.01% | 1253 |
|
|
2015
Q4 | $23.8M | Sell |
117,349
-24,290
| -17% | -$4.92M | 0.01% | 1031 |
|
|
2015
Q3 | $20.6M | Sell |
141,639
-3,574
| -2% | -$519K | ﹤0.01% | 1075 |
|
|
2015
Q2 | $30.9M | Sell |
145,213
-7,610
| -5% | -$1.62M | 0.01% | 996 |
|
|
2015
Q1 | $34.5M | Buy |
152,823
+1,658
| +1% | +$374K | 0.01% | 963 |
|
|
2014
Q4 | $33.9M | Buy |
+151,165
| New | +$33.9M | 0.01% | 975 |
|